Summary
Reduced expression of E-cadherin, a cell–cell adhesion molecule, is observed in oesophageal adenocarcinomas and correlates with less favourable pathological parameters and survival. To determine if genetic events lead to reduced E-cadherin expression in these patients, we screened all 16 exons of the E-cadherin gene for mutations with the polymerase chain reaction single-strand conformation polymorphism analysis (PCR-SSCP) technique in 49 resection specimens, including four loco-regional lymph node metastases, four established cell lines and four xenografts. Fifteen exon-spanning primer pairs were used, and in nine amplicons aberrant bands were detected. Sequencing of the amplicons revealed a one base-pair deletion (codon 120; exon 3) in cell lines JROECL 47 and JROECL 50 leading to a premature downstream stop codon. Polymorphisms were identified for amplicons 1, 4/5, 11, 12, 13, 14 and 16 corresponding with data from the literature. Three new polymorphisms were detected for amplicons 2, 3 and 4/5. Loss of heterozygosity (LOH) of the E-cadherin locus on 16q22.1 was examined with four polymorphic markers. LOH was found in 31 of the 48 informative cases (65%). These results show that, despite the frequent LOH of the E-cadherin locus, mutations in the E-cadherin gene are rare events and can not be held responsible for down-regulation of E-cadherin observed in the majority of adenocarcinomas of the oesophagus.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bailey, T., Biddlestone, L., Shepherd, N., Barr, H., Warner, P. & Jankowski, J. (1998). Altered cadherin and catenin complexes in the Barrett’s esophagus–dysplasia–adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am J Pathol 152: 135–144.
Becker, K. F. & Hofler, H. (1995). Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinomas. J Natl Cancer Inst 87: 1082–1084.
Becker, K. F., Atkinson, M. J., Reich, U., Becker, I., Nekarda, H., Siewert, J. R. & Hofler, H. (1994). E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54: 3845–3852.
Berx, G., Cleton-Jansen, A. M., Nollet, F., de Leeuw, W. J., van de Vijver, M., Cornelisse, C. & van Roy, F. (1995). E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. Embo J 14: 6107–6115.
Berx, G., Cleton-Jansen, A. M., Strumane, K., de Leeuw, W. J., Nollet, F., van Roy, F. & Cornelisse, C. (1996). E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13: 1919–1925.
Bongiorno, P. F., al-Kasspooles, M., Lee, S. W., Rachwal, W. J., Moore, J. H., Whyte, R. I., Orringer, M. B. & Beer, D. G. (1995). E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett’s oesophagus. Br J Cancer 71: 166–172.
de La Coste, A., Romagnolo, B., Billuart, P., Renard, C. A., Buendia, M. A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A. & Perret, C. (1998). Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95: 8847–8851.
Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Lochner, D. & Birchmeier, W. (1991). E-cadherin-mediated cell–cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173–185.
Gabbert, H. E., Mueller, W., Schneiders, A., Meier, S., Moll, R., Birchmeier, W. & Hommel, G. (1996). Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 69: 184–189.
Gayther, S. A., Gorringe, K. L., Ramus, S. J., Huntsman, D., Roviello, F., Grehan, N., Machado, J. C., Pinto, E., Seruca, R., Halling, K., MacLeod, P., Powell, S. M., Jackson, C. E., Ponder, B. A. J. & Caldas, C. (1998). Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 58: 4086–4089.
Graff, J. R., Greenberg, V. E., Herman, J. G., Westra, W. H., Boghaert, E. R., Ain, K. B., Saji, M., Zeiger, M. A., Zimmer, S. G. & Baylin, S. B. (1998). Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle’s cell, and poorly differentiated human thyroid carcinoma. Cancer Res 58: 2063–2066.
Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A. & Reeve, A. E. (1998). E-cadherin germline mutations in familial gastric cancer. Nature 392: 402–405.
Hiraguri, S., Godfrey, T., Nakamura, H., Graff, J., Collins, C., Shayesteh, L., Doggett, N., Johnson, K., Wheelock, M., Herman, J., Baylin, S., Pinkel, D. & Gray, J. (1998). Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res 58: 1972–1977.
Ilyas, M., Tomlinson, I. P., Hanby, A., Talbot, I. C. & Bodmer, W. F. (1997). Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. Gut 40: 654–659.
Iwao, K., Nakamori, S., Kameyama, M., Imaoka, S., Kinoshita, M., Fukui, T., Ishiguro, S., Nakamura, Y. & Miyoshi, Y. (1998). Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 58: 1021–1026.
Kawanishi, J., Kato, J., Sasaki, K., Fujii, S., Watanabe, N. & Niitsu, Y. (1995). Loss of E-cadherin-dependent cell–cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 15: 1175–1181.
Krishnadath, K. K., Tilanus, H. W., van Blankenstein, M., Hop, W. C., Kremers, E. D., Dinjens, W. N. & Bosman, F. T. (1997). Reduced expression of the cadherin–catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 182: 331–338.
Kuczyk, M., Serth, J., Machtens, S., Bokemeyer, C., Bathke, W., Stief, C. & Jonas, U. (1998). Expression of E-cadherin in primary prostate cancer: correlation with clinical features [In Process Citation]. Br J Urol 81: 406–412.
Oda, T., Kanai, Y., Oyama, T., Yoshiura, K., Shimoyama, Y., Birchmeier, W., Sugimura, T. & Hirohashi, S. (1994). E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 91: 1858–1862.
Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K. & Sekiya, T. (1989). Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766–2770.
Perl, A. K., Wilgenbus, P., Dahl, U., Semb, H. & Christofori, G. (1998). A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190–193.
Risinger, J. I., Berchuck, A., Kohler, M. F. & Boyd, J. (1994). Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet 7: 98–102.
Rockett, J. C., Larkin, K., Darnton, S. J., Morris, A. G. & Matthews, H. R. (1997). Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization. Br J Cancer 75: 258–263.
Saito, Y., Takazawa, H., Uzawa, K., Tanzawa, H. & Sato, K. (1998). Reduced expression of E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 5′ CpG island. Int J Oncol 12: 293–298.
Sheffield, V. C., Beck, J. S., Kwitek, A. E., Sandstrom, D. W. & Stone, E. M. (1993). The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 16: 325–332.
Shimoyama, Y., Nagafuchi, A., Fujita, S., Gotoh, M., Takeichi, M., Tsukita, S. & Hirohashi, S. (1992). Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell–cell adhesiveness. Cancer Res 52: 5770–5774.
Soares, P., Berx, G., van Roy, F. & Sobrinho-Simoes, M. (1997). E-cadherin gene alterations are rare events in thyroid tumors. Int J Cancer 70: 32–38.
Sulzer, M. A., Leers, M. P., van Noord, J. A., Bollen, E. C. & Theunissen, P. H. (1998). Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer. Am J Respir Crit Care Med 157: 1319–1323.
Swami, S., Kumble, S. & Triadafilopoulos, G. (1995). E-cadherin expression in gastroesophageal reflux disease, Barrett’s esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study. Am J Gastroenterol 90: 1808–1813.
Takeichi, M. (1991). Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451–1455.
Tamura, S. (1997). The E-cadherin-mediated cell–cell adhesion system in human cancers. Br J Surg 84: 899–900.
Trapman, J., Sleddens, H. F., van der Weiden, M. M., Dinjens, W. N., Konig, J. J., Schroder, F. H., Faber, P. W. & Bosman, F. T. (1994). Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54: 6061–6064.
Vleminckx, K., Vakaet, L., Jr Mareel, M., Fiers, W. & van Roy, F. (1991). Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107–119.
Vos, C. B., Cleton-Jansen, A. M., Berx, G., de Leeuw, W. J., ter Haar, N. T., van Roy, F., Cornelisse, C. J., Peterse, J. L. & van de Vijver, M. J. (1997). E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76: 1131–1133.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Wijnhoven, B., Both, N., Dekken, H. et al. E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus. Br J Cancer 80, 1652–1657 (1999). https://doi.org/10.1038/sj.bjc.6690577
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690577
Keywords
This article is cited by
-
OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer
Molecular Cancer (2014)
-
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
Nature Genetics (2013)
-
Loss of heterozygosity testing using real-time PCR analysis of single nucleotide polymorphisms
Journal of Cancer Research and Clinical Oncology (2006)
-
Alterations of E-cadherin and β-catenin in gastric cancer
BMC Cancer (2001)